USD $6.00-9.00 / Gram
USD $5.00-10.00 / Gram
USD $6.00-9.00 / Gram
USD $6.00-9.00 / Gram
USD $5.00-10.00 / Gram
USD $6.00-9.00 / Gram
USD $5.00-10.00 / Gram
USD $5.00-10.00 / Gram
USD $5.00-10.00 / Gram
we are very compeitive on tenofovir disoproxil fumarate.our mfr is gmp certified for this item with dmf document.
product name: | tenofovir disoproxil fumarate |
synonyms: | tdf |
cas: | 202138-50-9 |
mf: | c23h34n5o14p |
mw: | 635.52 |
einecs: | 687-766-5 |
product categories: | bases & related reagents;intermediates & fine chemicals;nucleotides;pharmaceuticals;phosphorylating and phosphitylating agents;inhibitors;tenofovir;api |
mol file: | 202138-50-9.mol |
overview | tenofovir disoproxil fumarate, a prodrug of tenofovir[trade name: “viread”] developed by gilead sciences, is a kind of nucleotide-analogues antiretroviral drugs, taking effect through acting as the reverse transcriptase inhibitors[nrtis], which block reverse transcriptase, an enzyme crucial to viral production in hiv-infected people[1-4]. it should be noted that it is the first nucleotide reverse transcriptase inhibitor that has ever used for the treatment of hiv infection[5]. tenofovir disoproxil fumarate is converted to tenofovir in vivo, which is an acyclic nucleoside phosphonate[nucleotide] analog of adenosine 5'-monophosphate[5,6]. it is generally used in combination with other kinds of medicine. hiv medicines can't cure hiv/aids, but taking a combination of hiv medicines[called an hiv regimen] every day can help people with hiv live longer, healthier lives[7]. based on the fda document, tenofovir disoproxil fumarate can also be for the treatment of chronic hepatitis b virus[hbv] infection in adults and children 12 years of age and older[1,3, 4, 8]. |
indication and application | tenofovir disoproxil fumarate[trade name: viread®], an antiviral drug, is indicated as the treatment for both hiv and hepatitis b virus[hbv]. viread® is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and pediatric patients 2 years of age and older. it is also indicated for the treatment of chronic hepatitis b in adults and pediatric patients 12 years of age and older |